PharmaVoice
MAY 16, 2025
A stealth startup built by the partner of disgraced Theranos founder Elizabeth Holmes is taking a shot at a new blood test — an area where other companies are already making strides.
MedCity News
MAY 16, 2025
Perhaps the most significant health policy of our time, it revolutionized coverage and access, as well as the way healthcare companies communicated.With its future uncertain, now is the time to look back on how it shaped a new era of healthcare marketing strategy and messaging. The post The Affordable Care Acts Lasting Impact On Healthcare Marketing appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MAY 16, 2025
In a medical breakthrough, a child diagnosed with a rare genetic disorder has received a bespoke CRISPR gene editing therapy to correct the mutation
MedCity News
MAY 16, 2025
Inozyme Pharmas main asset is in pivotal testing in children who have a rare enzyme deficiency that affects bones and blood vessels. BioMarin Pharmaceutical, already well established in enzyme replacement, said it will use its experience and infrastructure to grow the market for this product, potentially for several indications. The post BioMarins $270M Inozyme Acquisition Brings Drug That Could Become First for a Rare Disease appeared first on MedCity News.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
Pharmaceutical Technology
MAY 16, 2025
The Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) was terminated in April.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
MAY 16, 2025
Datavant and Aetion merger promises "faster, more actionable" real-world data insights across pharma's clinical and commercial lifecycle
MedCity News
MAY 16, 2025
Sprinter Health’s $55 million Series B round was led by General Catalyst and included participation from Andreessen Horowitz (a16z) Bio + Health, the Regents of the University of California, Google Ventures and Accel. The post Sprinter Health Raises $55M to Expand Home Health Services for Health Plans appeared first on MedCity News.
Pharma Marketing Network
MAY 16, 2025
In today’s digital landscape, the integration of artificial intelligence (AI) into healthcare social media marketing is revolutionizing how organizations engage with patients and professionals. As AI technologies become more sophisticated, they offer unprecedented opportunities to personalize content, predict trends, and optimize campaigns. This evolution is not just a trend but a fundamental shift in how healthcare entities communicate and build trust with their audiences.
Pharmaceutical Technology
MAY 16, 2025
The deal gives Lilly access to the companys RNA-editing platform to develop therapies for sensorineural hearing loss.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
European Pharmaceutical Review
MAY 16, 2025
Novo Nordisks current CEO, Lars Fruergaard Jrgensen, will step down. He remains in the position temporarily to support the transition to a new successor. The company cited this change to its executive leadership is due to the impact of recent market challenges, as well as the companys share price decline since mid-2024. This decision is in the best interest of the company and its shareholders, Novo Nordisk stated.
Pharmaceutical Technology
MAY 16, 2025
Pathos AI has raised $365m in a Series D funding round to widen its AI-enabled platform to advance the development of oncology drugs.
MedCity News
MAY 16, 2025
[Sponsored] The webinar, sponsored by PurpleLab and scheduled for May 22, will explore how healthcare sector companies can leverage real world data (RWD) with a focus on lung cancer. The post Using RWD to Improve Clinical Trial Recruitment, Endpoints, and Inform Market Access Strategies appeared first on MedCity News.
Pharmaceutical Technology
MAY 16, 2025
Experts predict growing pains as the life sciences sector moves to adapt to the EU AI Act.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
Pharmaceutical Commerce
MAY 16, 2025
In an exclusive sit-down with Pharma Commerce, Anne Cassity, senior vice president of government affairs for the National Community Pharmacists Association (NCPA), discusses pending legislation that could affect the impact of PBM pricing.
PharmExec
MAY 16, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
European Pharmaceutical Review
MAY 16, 2025
Earlier this week, the UK Government published new plans for the reform of its immigration strategy. The policy paper outlined three key aims: grow the UKs domestic workforce, end reliance on overseas labour and boost growth of its domestic economy. 1 Addressing the UK government’s immigration whitepaper Although the proposals in the UK government’s immigration whitepaper could deliver benefit for a range of sectors, the science industry are calling for confidence and clarity from go
PharmExec
MAY 16, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
pharmaphorum
MAY 16, 2025
Incyte has broken new ground in immuno-oncology, getting FDA approval for its Zynyz drug as a treatment for anal cancer
PharmExec
MAY 16, 2025
Tapping into the reader experience, our new comprehensive survey uncovers valuable input for navigating the changing tides facing pharma decision-makers.
Pharmacy Times
MAY 16, 2025
Aficamten, a cardiac myosin inhibitor, gains FDA approval, offering hope for improved cardiovascular health in patients with obstructive hypertrophic cardiomyopathy.
pharmaphorum
MAY 16, 2025
Novo Nordisk's chief executive Lars Fruergaard Jrgensen is stepping down by "mutual agreement" with the company's board
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Pharmacy Times
MAY 16, 2025
Specialty pharmacists enhance CKD management through personalized care, medication adherence strategies, and collaboration with health care providers.
Scott’s Directories
MAY 16, 2025
In a competitive market, identifying prospects who are ready to buy is critical. High-intent leads are those already considering a solution and actively seeking a provider. These leads convert faster and with fewer touchpoints. To boost performance, companies must optimize their online presence for Healthcare sales lead generation. Digital strategy plays a central role in capturing the right traffic and converting interest into action.
Pharmacy Times
MAY 16, 2025
A new study reveals that heart failure patients with implantable devices are more likely to receive the pneumococcal conjugate vaccine 13, impacting vaccination rates and mortality.
MedCity News
MAY 16, 2025
Breakthroughs in synthetic biology could help accelerate advances in applications from novel infectious disease vaccines, precision immunotherapy for cancer and antibody therapeutics to creation of engineered meat substitutes and sustainable cellular agricultural products. The post Driving Synthetic Biology Forward Through Adoption of Technology Enabling Rapid DNA and mRNA Synthesis appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmacy Times
MAY 16, 2025
Omalizumab expands its role in allergy management, now FDA-approved for food allergies, showcasing potential for broader applications in allergic rhinitis.
Pharmaceutical Technology
MAY 16, 2025
Artificial Intelligence (AI) is now used throughout clinical trials, from recruitment to analysis but are regulators keeping up?
Pharmacy Times
MAY 16, 2025
Implementation of a guidance document for periprocedural antibiotic prophylaxis resulted in improved appropriateness of antibiotic dose, selection, and duration for interventional radiology procedures.
Expert insights. Personalized for you.
235 
Let's personalize your content